Edgewise Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$13.52(as of Aug 6, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Edgewise Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$13.52
Ticker SymbolEWTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees117
CountyUSA
Market Cap$1,445.4M

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The company was incorporated in 2017 and is headquartered in Boulder, Colorado.

Edgewise Therapeutics Inc In Our Stock Scanner

As of Aug 07, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.